Sorrento Therapeutics

SARS-CoV-2

Pharma

Sorrento pitches lymphatic delivery for COVID-19 dose sparing

Sorrento Therapeutics has presented preclinical data suggesting vaccine delivery to lymph nodes can slash the dose required to generate immunity.

Nick Paul Taylor Aug 31, 2021 7:45am

signing contract

Sorrento moves to buy delayed burst release naltrexone drug

Mar 9, 2021 9:15am

Starting

3SBio in CAR-T pact with Sorrento

Jun 8, 2016 4:32am